专利名称:GENERATION OF ANTIBODIES TO TUMOR
ANTIGENS AND GENERATION OF TUMORSPECIFIC COMPLEMENT DEPENDENTCYTOTOXICITY BY ADMINISTRATION OFONCOLYTIC VACCINIA VIRUS
发明人:David KIRN,John BELL,Caroline
BREITBACH,Anne MOON,Tae-Ho HWANG,YuKyoung LEE,Mi-kyung KIM
申请号:US15892247申请日:20180208
公开号:US20180214538A1公开日:20180802
摘要:The present invention relates to methods and compositions for use in inducingtumor-specific antibody mediated complement-dependent cytotoxic response in ananimal having a tumor comprising administering to said animal a composition comprisinga replication competent oncolytic virus wherein administration of the composition inducesin the animal production of antibodies that mediate a CDC response specific to saidtumor.
申请人:SILLAJEN BIOTHERAPEUTICS, INC.,SILLAJEN, INC.
地址:San Francisco CA US,Busan KR
国籍:US,KR
更多信息请下载全文后查看
因篇幅问题不能全部显示,请点此查看更多更全内容